Cordance Demonstrates Multi-Site Blood-Brain Barrier Openings in Pre-Clinical Study

Cordance Medical Successful in Pre-Clinical Studies

Cordance Medical Awarded United States Patent for Methods in Opening the Blood-Brain Barrier

Cordance Medical technology presented at the Society for Neuro-Oncology Annual Meeting

Cordance Medical accepted into Endless Frontier Labs Deep Technology Accelerator

Cordance Medical accepted into Creative Destructive Labs Neurology Accelerator

Cordance Medical awarded Phase II National Science Foundation Award

Cordance Medical appoints Ryan Dittamore as Chief Executive Officer